+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Forecast 2024-2030- Product Image
Global Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Forecast 2024-2030- Product Image
Sale

Global Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968715
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Excipient Market size was estimated at USD 8.62 billion in 2023, USD 9.20 billion in 2024, and is expected to grow at a CAGR of 6.74% to reach USD 13.62 billion by 2030.

Pharmaceutical excipients are added to pharmaceutical products for various purposes, including improving the manufacturing process, enhancing stability, ensuring the bioavailability of the drug, and facilitating the administration and dosing of the final product. Excipients are essentially inactive components that support the overall formulation and delivery of the active ingredient. The market for pharmaceutical excipients is primarily driven by the increasing demand for pharmaceutical products due to the rising global population and chronic diseases. Technological advancements in drug formulation and developing novel excipients also contribute to market growth. Furthermore, the expansion of the generic pharmaceuticals sector and the trend toward self-medication for minor health issues provide a strong impetus for the excipient market. However, stringent regulatory requirements leading to lengthy approval processes can impede the introduction of new excipients, and the high cost associated with developing and producing advanced excipients hamper its market growth. The shift toward multifunctional and co-processed excipients and ongoing advancements and research activities for developing biobased excipients opens significant opportunities for market players, offering benefits such as improved product performance and production efficiency.

Regional Insights

The Americas region has a significant landscape in the pharmaceutical excipient market as countries exhibit a high demand for excipients, directed by stringent regulatory environments, advanced healthcare systems, and strong intellectual property frameworks. Having a significant landscape in pharmaceutical innovation, the countries in the region strongly focus on advanced and novel excipients for drug formulations. The EMEA region, which encompasses Europe, the Middle East, and Africa, shows diverse market characteristics. The stringent regulatory environment in the European Union drives the demand for compliant and high-quality excipients, whereas markets in the Middle East and Africa are burgeoning, with increasing investment in pharmaceutical manufacturing infrastructure and regulation. The EU market demonstrates a high need for cutting-edge pharmaceutical excipients that cater to complex drugs and sophisticated drug delivery systems. Moreover, the EU's investment in biopharmaceuticals and biosimilars is complemented by the growing demand for novel excipients in these areas. Countries in the Asia-Pacific region are key players in the pharmaceutical excipient sector experiencing substantial growth due to a large patient pool, increasing healthcare expenditures, and supportive government initiatives. The region focuses on innovating high-functional excipients with ongoing research and development, reducing its historical reliance on imports.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Excipient Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Excipient Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Aceto Corp., Archer Daniels Midland Company, ARMOR PROTEINES S.A.S., Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG, DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc., International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L’AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, R.T. Vanderbilt Holding Company, Inc., Resonac Holdings Corporation, Roquette Frères S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Excipient Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Inorganic
      • Calcium Carbonate
      • Calcium Phosphate
      • Calcium Sulfate
      • Halites
      • Metal Oxides
    • Organic
      • Carbohydrates
        • Cellulose
        • Starch
        • Sugars
      • Oleochemicals
        • Fatty Alcohols
        • Glycerin
        • Mineral Stearates
      • Petrochemicals
        • Acrylic Polymers
        • Glycols
        • Mineral Hydrocarbons
        • Povidones
      • Proteins
  • Formulation
    • Oral Formulations
      • Capsules
        • Hard Gelatin Capsules
        • Soft Gelatin Capsules
      • Liquid Formulations
      • Tablets
    • Parenteral Formulations
    • Topical Formulations
  • Function
    • Binders
    • Coating Agents
    • Colorants
    • Disintegrants
    • Emulsifying Agents
    • Fillers & Diluents
    • Flavoring Agents & Sweeteners
    • Lubricants & Glidants
    • Preservatives
    • Suspending & Viscosity Agents
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pharmaceutical Excipient Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Excipient Market?
  3. What are the technology trends and regulatory frameworks in the Pharmaceutical Excipient Market?
  4. What is the market share of the leading vendors in the Pharmaceutical Excipient Market?
  5. Which modes and strategic moves are suitable for entering the Pharmaceutical Excipient Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharmaceutical Excipient Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
5.1.1.2. Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
5.1.1.3. Significant emphasis on the production of multifunctional excipients
5.1.2. Restraints
5.1.2.1. High cost associated with the production of advanced excipient
5.1.3. Opportunities
5.1.3.1. Technological advancements in nanotechnology for excipients
5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
5.1.4. Challenges
5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
5.2. Market Segmentation Analysis
5.2.1. Type: Potential demand and utilization of organic excipients
5.2.2. Formulation: Significant demand for oral formulations owing to its convenient drug delivery
5.2.3. Function: Coating agents provide physical and chemical protection for the drug
5.3. Market Trend Analysis
5.3.1. Substantial investments to increase drug manufacturing to propel the demand for pharmaceutical excipient in the Americas
5.3.2. Supportive government initiatives to encourage exports of pharmaceutical products in the Asia-Pacific
5.3.3. Flourishing pharmaceutical sector, coupled with a growing focus on localizing drug manufacturing in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pharmaceutical Excipient Market, by Type
6.1. Introduction
6.2. Inorganic
6.3.1. Calcium Carbonate
6.3.2. Calcium Phosphate
6.3.3. Calcium Sulfate
6.3.4. Halites
6.3.5. Metal Oxides
6.3. Organic
6.4.1. Carbohydrates
6.4.2.1. Cellulose
6.4.2.2. Starch
6.4.2.3. Sugars
6.4.2. Oleochemicals
6.4.3.1. Fatty Alcohols
6.4.3.2. Glycerin
6.4.3.3. Mineral Stearates
6.4.3. Petrochemicals
6.4.4.1. Acrylic Polymers
6.4.4.2. Glycols
6.4.4.3. Mineral Hydrocarbons
6.4.4.4. Povidones
6.4.4. Proteins
7. Pharmaceutical Excipient Market, by Formulation
7.1. Introduction
7.2. Oral Formulations
7.3.1. Capsules
7.3.2.1. Hard Gelatin Capsules
7.3.2.2. Soft Gelatin Capsules
7.3.2. Liquid Formulations
7.3.3. Tablets
7.3. Parenteral Formulations
7.4. Topical Formulations
8. Pharmaceutical Excipient Market, by Function
8.1. Introduction
8.2. Binders
8.3. Coating Agents
8.4. Colorants
8.5. Disintegrants
8.6. Emulsifying Agents
8.7. Fillers & Diluents
8.8. Flavoring Agents & Sweeteners
8.9. Lubricants & Glidants
8.10. Preservatives
8.11. Suspending & Viscosity Agents
9. Americas Pharmaceutical Excipient Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Excipient Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pharmaceutical Excipient Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
12.3.2.2. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
12.3.2.3. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
12.3.3. New Product Launch & Enhancement
12.3.3.1. Roquette Introduces New Advancement in Moisture Protection
12.3.3.2. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
12.3.3.3. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
12.3.3.4. Lubrizol Launches Apisolex Technology
12.3.4. Investment & Funding
12.3.4.1. Ingredion Announces Strategic Investments Expanding Into High-Value Pharmaceutical Ingredients
12.3.5. Award, Recognition, & Expansion
12.3.5.1. Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
12.3.5.2. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. ABITEC Corporation
13.1.2. Aceto Corp.
13.1.3. Archer Daniels Midland Company
13.1.4. ARMOR PROTEINES S.A.S.
13.1.5. Asahi Kasei Corporation
13.1.6. Ashland Inc.
13.1.7. BASF SE
13.1.8. BIOGRUND GmbH
13.1.9. Chemische Fabrik Budenheim KG
13.1.10. Clariant AG
13.1.11. Colorcon Inc.
13.1.12. Corel Pharma Chem Private Limited
13.1.13. Croda International Plc
13.1.14. Darling Ingredients, Inc.
13.1.15. DFE Pharma GmbH & Co KG
13.1.16. DuPont de Nemours, Inc.
13.1.17. Evonik Industries AG
13.1.18. Fuji Chemical Industries Co., Ltd.
13.1.19. GATTEFOSSE SAS
13.1.20. Innophos Holdings, Inc.
13.1.21. International Flavors & Fragrances Inc.
13.1.22. JRS PHARMA GmbH + Co. KG
13.1.23. Kerry Group P.L.C.
13.1.24. Lipoid GmbH
13.1.25. Lubrizol Corporation
13.1.26. L’AIR LIQUIDE S.A.
13.1.27. Mallinckrodt plc
13.1.28. MEGGLE GmbH & Co. KG
13.1.29. Merck KGaA
13.1.30. Nagase & Co., Ltd.
13.1.31. Nipon Soda Co., Ltd.
13.1.32. NOF Corporation
13.1.33. Omya International AG
13.1.34. Peter Greven GmbH & Co. KG
13.1.35. R.T. Vanderbilt Holding Company, Inc.
13.1.36. Resonac Holdings Corporation
13.1.37. Roquette Frères S.A.
13.1.38. Shin-Etsu Chemical Co., Ltd.
13.1.39. Solvay S.A.
13.1.40. SPI Pharma, Inc.
13.1.41. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2023 VS 2030
FIGURE 3. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMACEUTICAL EXCIPIENT MARKET DYNAMICS
FIGURE 7. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 10. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 12. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 8. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 15. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 17. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 22. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 27. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 33. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 35. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 37. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 44. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 85. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 87. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 88. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 89. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 90. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 91. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 93. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 94. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 97. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 98. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 102. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 104. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 137. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 139. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 140. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 141. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 142. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 143. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 144. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 145. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 146. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 147. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 149. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 150. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 151. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 152. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 153. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 155. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 156. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 167. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 169. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 170. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 171. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 172. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 173. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 175. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 176. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 189. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 190. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 191. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 192. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 193. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 199. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 200. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 201. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 202. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 203. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 209. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 210. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 211. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 212. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 213. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 214. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 219. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 220. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 221. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 222. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 223. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 224. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 225. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 227. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 229. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 230. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 231. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 232. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 233. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 235. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 236. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 239. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 240. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 241. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 242. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 243. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 244. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 245. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 246. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 258. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 260. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 261. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 262. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 263. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 264. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 265. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 266. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 267. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 268. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 270. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 271. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 272. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 273. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 274. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 275. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 276. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 277. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 278. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 280. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 281. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 282. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 283. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 284. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 285. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 286. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 287. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 288. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 290. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 291. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 292. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 293. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 294. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 295. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 296. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 297. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 298. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 299. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 300. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 301. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 302. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 303. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 304. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 305. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 306. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 307. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 308. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 310. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 311. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 318. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 319. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 320. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 321. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 322. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 323. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 324. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 325. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 326. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 327. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2018-2030 (USD M

Companies Mentioned

  • ABITEC Corporation
  • Aceto Corp.
  • Archer Daniels Midland Company
  • ARMOR PROTEINES S.A.S.
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • BIOGRUND GmbH
  • Chemische Fabrik Budenheim KG
  • Clariant AG
  • Colorcon Inc.
  • Corel Pharma Chem Private Limited
  • Croda International Plc
  • Darling Ingredients, Inc.
  • DFE Pharma GmbH & Co KG
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group P.L.C.
  • Lipoid GmbH
  • Lubrizol Corporation
  • L’AIR LIQUIDE S.A.
  • Mallinckrodt plc
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Nagase & Co., Ltd.
  • Nipon Soda Co., Ltd.
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • R.T. Vanderbilt Holding Company, Inc.
  • Resonac Holdings Corporation
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay S.A.
  • SPI Pharma, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.62 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned41

Related Topics

Related Reports

Global Organic Pharmaceutical Excipients Market by Function (Binders, Coating Agents, Colorants), Form (Oral Formulations, Parenteral Formulations, Topical Formulations), Product - Forecast 2024-2030 - Product Image

Global Organic Pharmaceutical Excipients Market by Function (Binders, Coating Agents, Colorants), Form (Oral Formulations, Parenteral Formulations, Topical Formulations), Product - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Pharmaceutical Excipients Market by Product (Organic (Oleochemicals, Carbohydrates) Inorganic (Calcium Carbonate), Functionality (Fillers, Binders, Lubricants, Diluents), Formulation (Oral, Parenteral), Application (Stablizers) - Global Forecast to 2028 - Product Image

Pharmaceutical Excipients Market by Product (Organic (Oleochemicals, Carbohydrates) Inorganic (Calcium Carbonate), Functionality (Fillers, Binders, Lubricants, Diluents), Formulation (Oral, Parenteral), Application (Stablizers) - Global Forecast to 2028

  • Report
  • 504 Pages
  • Global
From
Organic Pharmaceutical Excipients Global Market Report 2024 - Product Image

Organic Pharmaceutical Excipients Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Forecast 2023-2030 - Product Image

Global Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Forecast 2023-2030

  • Report
  • 180 Pages
  • Global
From
Global Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region - Forecast to 2028 - Product Image

Global Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region - Forecast to 2028

  • Report
  • 379 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.